OnKure Therapeutics, Inc. (OKUR) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $59.05M | -46.7% |
| 2024 | $110.76M | +270.7% |
| 2023 | $29.88M | +49.9% |
| 2022 | $19.93M | -84.0% |
| 2021 | $124.66M | +132.5% |
| 2020 | $53.61M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $59.05M | -46.7% |
| 2024 | $110.76M | +270.7% |
| 2023 | $29.88M | +49.9% |
| 2022 | $19.93M | -84.0% |
| 2021 | $124.66M | +132.5% |
| 2020 | $53.61M | — |